Давид Хаят - Антираковая диета. Продукты, которые мы должны есть, чтобы защититься от опасного недуга Страница 41

{7} Plymate S. R., Jones R. E., Matej L. A., Friedl K. E., «Regulation of sex hormone binding globulin (SHBG) production in Hep G2 cells by insulin», Steroids, 1988, 52 (4), p. 339–340.

{8} Silvera S. A. N., Rohan T. E., Jain M., Terry P. D., Howe G., Miller A., «Glycemic index, glycemic load, and pancreatic cancer risk (Canada)», Cancer causes et control, 2005, CCC 16 (4), p. 431–436.

{9} Augustin L. S., Franceschi S., Jenkins D., Kendall C., La Vecchia C., «Glycemic index in chronic disease: A review», European Journal of Clinical Nutrition, 2002, 56 (11), p. 1049–1071.

{10} Cust A., Slimani N. et al., «Dietary carbohydrates, glycemic index, glycemic load, and endometrial cancer risk within the European prospective investigation into cancer and nutrition cohort», American Journal of Epidemiology, 2007, 166 (8), p. 912–923.

{11} Larsson S., Bergkvist L., Wolk A., «Glycemic load, glycemic index and breast cancer risk in a prospective cohort of Swedish women», Int. J. Cancer, 2009, 125, p. 153–157.

{12} Lajous M., Boutron-Ruault M. C., Fabre A., Clavel-Chapelon F., Romieu Y., «Carbohydrate intake, glycemic index, glycemic load, and risk of postmenopausal breast cancer in a prospective study of French women», The American Journal of Clinical Nutrition, 2008, 87 (5), p. 1384–1391.

{13} Mulholland H. G., Murray L. J., Cardwell C. R., Cantwell M. M., «Glycemic index, glycemic load, and risk of digestive tract neoplasms: A systematic review and meta-analysis», The American Journal of Clinical Nutrition, 2009, 89 (2), p. 568–576.

{14} Michaud D. S., Fuchs C. S., Liu S., Willett W. C., Colditz G. A., Giovannucci E., «Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women», Cancer Epidemiology, Biomarkers & Prevention, publié par l’American Association for Cancer Research, 2005, 14 (1), p. 138–147.

{15} Mulholland H. G., Murray L. J., Cardwell C. R., Cantwell M. M., «Glycemic index, glycemic load, and risk of digestive tract neoplasms: A systematic review and meta-analysis», op. cit.

{16} Howarth N. C., Murphy S. P., Wilkens L. R., Henderson B. E., Kolonel L. N., «The association of glycemic load and carbohydrate intake with colorectal cancer risk in the Multiethnic Cohort Study», The American Journal of Clinical Nutrition, 2008, 88 (4), p. 1074–1082.

{17} American Cancer Society, Prevention and Early Detection: Aspartame, 2007. Disponible en ligne sur: http://www.cancer.org/docroot/ PED/content/PED_1_3X_Aspartame.asp (consulté le 17 mars 2010).

{18} Ibid.

{19} Phillips K. M., Carlsen M. H., Blomhoff R., «Total antioxidant content of alternatives to refined sugar», Journal of the American Dietetic Association, 2009, 109 (1), p. 64–71.

{20} AFSSA, Avis de l’Agence française de sécurité sanitaire des aliments relatif à une autorisation provisoire, pour une durée de deux ans, d’emploi de stéviol, extraits de Stevia rebaudiana, en tant qu’édulcorant en alimentation humaine dans le cadre de l’article 5 de la directive 89/107/ CEE, 2007. Disponible sur: http://www.afssa.fr/Documents/ AAAT2006sa0231.pdf (consulté le 25 mars 2010).

{21} Arrêté du 26 août 2009 relatif à l’emploi du rébaudioside A (extrait de Stevia rebaudianaj comme additif alimentaire. Disponible sur: http:// www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTE XT000021021759 (consulté le 24 mars 2010).

{1} CNRS, Découvrir l’eau. L’eau dans l’organisme. Disponible sur: http://www.cnrs.fr/cw/dossiers/doseau/decouv/usages/eauOrga.html (consulté le 17 mars 2010).

{2} OMS, Communiqué de presse: Selon un nouveau rapport, la réalisation des cibles en matière d’assainissement et d’eau potable serait compromise, 2006. Disponible sur http://www.who.int/mediacentre/ news/releases/2006/pr47/fr/index.html (consulté le 17 mars 2010).

{3} OMS, La Santé et les services d’approvisionnement en eau de boisson salubre et d’assainissement de base. Disponible sur: http://www.who.int/ water_sanitation_health/mdg1/fr/index.html (consulté le 17 mars 2010).

{4} Direction générale de la santé, Bureau de la qualité des eaux, Bilan de la qualité de l’eau au robinet du consommateur vis-à-vis des pesticides en 2008, 2008. Disponible sur: http://www.sante-sports.gouv.fr/IMG/ pdf/bilannational_pesticides_2008.pdf (consulté le 17 mars 2010).

{5} Ibid.

{6} OMS, L’Arsenic dans l’eau de boisson, 2001. Disponible sur http:// www.who.int/water_sanitation_health/mdg1/fr/index.html (consulté le 17 mars 2010).

{7} Ibid.

{8} World Cancer Research Fund, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective, op. cit.

{9} Sénat, Rapport de l’OPECST, n° 2152 (2002–2003) de M. Gérard Miquel, fait au nom de l’Office parlementaire d’évaluation des choix scient. tech., déposé le 18 mars 2003. La Qualité de l’eau et assainissement en France. Annexe 63. L’arsenic dans les eaux de boisson. Disponible sur: http://www.senat.fr/rap/l02-215-2/l02-215-256.html#toc124 (consulté le 17 mars 2010).

{10} Ibid.

{11} Centre international de recherche sur le cancer, Evaluations globales de la cancérogénicité pour l’Homme. Disponible sur: http://monographs. iarc.fr/FR/Classification/crthall.php (consulté le 07/03/2010).

{12} DGS, Résultats du contrôle sanitaire de la qualité de l’eau potable, 2009. Disponible sur: http://www.sante-sports.gouv.fr/resultats-du-controle-sanitaire-de-la-qualite-de-l-eau-potable.html (consulté le 17 mars 2010).

{13} Ibid.

{14} Institut national du cancer, Alcool et risque de cancer, 2007. Disponible sur: http://www.e-cancer.fr/la-sante-publique/prevention/ alcoolisme (consulté le 17 mars 2010).

{15} Haut Conseil du ministère de la Santé, Avis relatif aux recommandations sanitaires en matière de consommation d’alcool, 2009. Disponible sur: http://www.hcsp.fr/docspdf/avisrapports/hcspa20090701_alcool.pdf (consulté le 17 mars 2010).

{16} World Cancer Research Fund, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective, op. cit.

{17} Ibid.

{18} Fakhry C., Gillison M. L., «Clinical implications of human papillomavirus in head and neck cancers», J. Clin. Oncol., 2006, 24 (17), p. 2606–2611.

{19} World Cancer Research Fund, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective, op. cit.

{20} Ibid.

{21} Ibid.

{22} Haut Conseil du ministère de la Santé, Avis relatif aux recommandations sanitaires en matière de consommation d’alcool, op.cit.

{23} Sun W., Wang W., Kim J., Keng P., Yang S., Zhang H., Liu C., Okunieff P., Zhang L., «Anticancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignent», Adv. Exp. Med. Biol., 2008, 614, p. 179–186.

{24} Aprifel, Rôle bénéfique des polyphénols et du resvératrol du vin, 2001. Disponible sur: http://www.aprifel.com/articles-sante,detail. php?m=3&rub=54&a =769 (consulté le 17 mars 2010).

{25} Adrian et al., Am. J. Enol. Viti c., 2000, 51, p. 37–41.

{26} Renaud S., Lorgeril M. de, «Wine, alcohol, platelets, and the French paradox for coronary heart disease», Lancet, 1992, 339 (8808), p. 1523–1526.

{27} Brisdelli F., D’Andrea G., Bozzi A., «Resveratrol: A natural polyphenol with multiple chemopreventive properties», Curr. Drug Metab., 2009, 10 (6), p. 530–546.

{28} Athar M., Back J. H., Kopelovich L., Bickers D. R., Kim A. L., «Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms», Arch. Biochem. Biophys., 2009, 486 (2), p. 95—102.

{29} Yusuf N., Nasti T. H., Meleth S., «Elmets CA. Resveratrol enhances cellmediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis», Mol. Carcinog., 2009, 48 (8), p. 713–723.

{30} Seeni A., Takahashi S., Takeshita K., Tang M., Sugiura S., Sato S. Y., Shirai T., «Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model», Asian Pac. J. Cancer Prev., 2008, 9 (1), p. 7—14.

{31} Sengottuvelan M., Deeptha K., Nalini N., «Influence of dietary resveratrol on early and late molecular markers of 1,2-dimethylhydrazineinduced colon carcinogenesis», Nutrition, 2009, 25 (11–12), p. 1169–1176.

{32} Ding X. Z., Adrian T. E., «Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells», Pancreas, 2002, 25 (4), p. 71–76.

{33} Woodall C. E., Li Y., Liu Q. H., Wo J., Martin R. C., «Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation», Anticancer Drugs, 2009, 20 (6), p. 437–443.

{34} AFSSA, «Table CIQUAL 2008», op. cit.

{35} Direction générale de la Santé, Cancer de la peau. Mélanome, 2003. Disponible sur: http://www.sante.gouv.fr/htm/dossiers/losp/34cancer_ peau.pdf (consulté le 18 mars 2010).

{36} AFSSET, FAQ Rayonnement ultraviolet. Disponible sur: http:// www.afsset.fr/index.php?pageid=634 & parentid=265&ongletlstid=427 (consulté le 17 mars 2010).

{37} Sayre R. M., Dowdy J. C., «The increase in melanoma: are dietary furocoumarins responsable?», Med Hypotheses, 2008, 70 (4), p. 855–859.

{38} Feskanich D., Willett W. C., Hunter D. J., Colditz G. A., «Dietary intakes of vitamins A, C, and E and risk of melanoma in two cohorts of women», Br. J. Cancer, 2003, 88 (9), p. 1381–1387.

{39} Malik A., Afaq F., Sarfaraz S., Adhami V. M., Syed D. N., Mukhtar H., «Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer», Proc. Natl. Acad. Sci., 2005, 102 (41), p. 14813—14818.

{40} Pantuck A. J., Leppert J. T., Zomorodian N., Aronson W., Hong J., Barnard R. J., Seeram N., Liker H., Wang H., Elashoff R., Heber D., Aviram M., Ignarro L., Belldegrun A., «Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer», Clin. Cancer Res., 2006, 12 (13), p. 4018–4026.

{41} Zhang Y., Seeram N. P., Heber D., Chen S., Adams L. S., «Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro», Cancer Prev. Res. (Phila Pa), 2010, 3 (1), p. 108–113.

{42} Khan G. N., Gorin M. A., Rosenthal D., Pan Q., Bao L. W., Wu Z. F., Newman R. A., Pawlus A. D., Yang P., Lansky E. P., Merajver S. D., «Pomegranate fruit extract impairs invasion and motility in human breast cancer», Integr. Cancer Ther., 2009, 8 (3), p. 242–253.

{43} Seeram N. P. et al., «In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice», J. Nutr. Biochem., 2005, 16 (6), p. 360–367.

{44} Gil M. I., Tomâs-Barberân F. A., Hess-Pierce B., Holcroft D. M., Kader A. A., «Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing», J. Agric. Food Chem., 2000, 48 (10), p. 4581–4589.

{45} Khan N., Afaq F., Kweon M. H., Kim K., Mukhtar H., «Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice», Cancer Res, 2007, 67 (7), p. 3475–3482.

{46} Gil M. I., Tomâs-Barberân F. A., Hess-Pierce B., Holcroft D. M., Kader A. A., «Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing», op. cit.

{47} Khan N., Afaq F., Kweon M. H., Kim K., Mukhtar H. «Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice», Cancer Res, 2007, 67 (7), p. 3475–3482.

{48} Pantuck A. J., Leppert J. T., Zomorodian N., Aronson W., Hong J., Barnard R. J., Seeram N., Liker H., Wang H., Elashoff R., Heber D., Aviram M., Ignarro L., Belldegrun A., «Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer», Clin. Cancer Res., 2006, 2 (13), p. 4018–4026.

{49} Gil M. I., Tomâs-Barberân F. A., Hess-Pierce B., Holcroft D. M., Kader A. A., «Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing», op. cit.

{50} MacMahon B., Yen S., Trichopoulos D., Warren K., Nardi G. «Coffee and cancer of the pancreas», N. Engl. J. Med., 1981, 304 (11), p. 630–633.

{51} Nkondjock A., «Coffee consumption and the risk of cancer: An overview», Cancer Lett., 2008, 277 (2), p. 121–125.

{52} World Cancer Research Fund, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective, op. cit.

{53} Pelucchi C., Tavani A., La Vecchia C., «Coffee and alcohol consumption and bladder cancer», Scand. J. Urol. Nephrol., 2008, 218, suppl., p. 37–44.

{54} Baker J. A., Beehler G. P., Sawant A. C., Jayaprakash V., Mc-Cann S. E., Moysich K. B., «Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer», J. Nutr., 2006, 136 (1), p. 166–171.

{55} Nkondjock A., Ghadirian P., Kotsopoulos J., Lubinski J., Lynch H., Kim Sing C., Horsman D., Rosen B., Isaacs C., Weber B., Foulkes W., Ainsworth P., Tung N., Eisen A., Friedman E., Eng C., Sun P., Narod S. A., «Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers», Int. J. Cancer, 2006, 118 (1), p. 103–107.

{56} Shanafelt T. D., Lee Y. K., Call T. G., Nowakowski G. S., Dingli D., Zent C. S., Kay N. E., «Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies», Leuk. Res., 2006, 30 (6), p. 707–712.